Porter Ranch, CA, United States of America

Lali K Medina-Kauwe

This inventor holds 13 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 5 EPO patents, primarily in Targeted Drug Delivery. Top assignee: Cedars-Sinai Medical Center. Active years: 2015-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lali K Medina-Kauwe. Retrieved from https://idiyas.com/inventor/lali-k-medina-kauwe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 13 (Patent Applications = 4)

% Patents Active = 92.3

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 5 (Patent Applications = 7)

Average Co-Inventor Count = 1.1

ph-index = 4

Forward Citations = 39(Granted Patents)

Location History:

Los Angeles, CA (US) (2017 - 2019)
Porter Ranch, CA (US) (2015 - 2023)

Company Filing History:

13 out of 628

Cedars-Sinai Medical Center

patents

Years Active: 2015-2025

Loading Chart...

Areas of Expertise:

Receptor Targeting

Drug Delivery

Targeted Delivery System

Tumor Targeting

Self-Assembling Complex

Corroles

MRI

Traffic-Enhancing Mutants

Nanoparticle

Chemical Agents

HER2+ Breast Cancer

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12502351 - RECEPTOR TARGETING CONSTRUCTS AND USES THEREOF (2025-12-23),

2. 11795454 - Targeted delivery system (2023-10-24),

3. 11369687 - Receptor targeting constructs and uses thereof (2022-06-28),

4. 10793853 - Targeted delivery system (2020-10-06),

5. 10752893 - Isolating traffic-enhancing mutants of drug delivery protein (2020-08-25),

6. 10709801 - Targeting corroles for tumor toxicity and MRI (2020-07-14),

7. 10391180 - Self-assembling complex for targeting chemical agents to cells (2019-08-27),

8. 10183078 - Receptor targeting constructs and uses thereof (2019-01-22),

9. 10036009 - Isolating traffic-enhancing mutants of drug delivery protein (2018-07-31),

10. 9850293 - Targeting trastuzumab-resistant HER2+ breast cancer with a HER3-targeting nanoparticle (2017-12-26),

11. 9789201 - Self-assembling complex for targeting chemical agents to cells (2017-10-17),

12. 9757386 - Targeting corroles for tumor toxicity and MRI (2017-09-12),

13. 9078927 - Self-assembling complex for targeting chemical agents to cells (2015-07-14),

Title: Lali K Medina-Kauwe: Innovator in Targeted Delivery Systems

Introduction

Lali K Medina-Kauwe is a prominent inventor based in Porter Ranch, CA (US). She has made significant contributions to the field of targeted delivery systems, particularly in the realm of cancer treatment. With a total of 13 patents to her name, her work is at the forefront of innovative medical technologies.

Latest Patents

One of her latest patents is titled "Receptor Targeting Constructs and Uses Thereof." This invention focuses on a targeted delivery system for siRNA or antisense technology. In one embodiment, the invention provides a method of treating cancer by administering a therapeutically effective dosage of HerPBK10 combined with siRNA. This combination results in the inhibition of Her2 expression and promotes cell death. Additionally, a plurality of HerPBK10 combined with siRNA can form a nanoparticle, enhancing the effectiveness of the treatment.

Career Highlights

Lali K Medina-Kauwe is affiliated with Cedars-Sinai Medical Center, where she continues to advance her research and innovations. Her work has garnered attention for its potential to revolutionize cancer therapies and improve patient outcomes.

Collaborations

Some of her notable coworkers include Jessica Sims and Michael Taguaim, who contribute to her research efforts and collaborative projects.

Conclusion

Lali K Medina-Kauwe is a trailblazer in the field of targeted delivery systems, with a focus on innovative cancer treatments. Her contributions through her patents and collaborations are paving the way for advancements in medical technology.

Profile summary based on public USPTO records.